PMC:7077337 / 40141-41078
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1133 | 4-21 | Species | denotes | novel coronavirus | Tax:2697049 |
| 1134 | 294-302 | Species | denotes | MERS-CoV | Tax:1335626 |
| 1135 | 345-353 | Species | denotes | MERS-CoV | Tax:1335626 |
| 1136 | 604-612 | Species | denotes | MERS-CoV | Tax:1335626 |
| 1137 | 694-703 | Species | denotes | 2019-nCoV | Tax:2697049 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T86 | 494-502 | Body_part | denotes | backbone | http://purl.org/sig/ont/fma/fma13478 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T277 | 441-444 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | aim |
| T278 | 716-717 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T279 | 790-803 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organizations |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T21 | 285-288 | Chemical | denotes | TPP | http://purl.obolibrary.org/obo/CHEBI_35033|http://purl.obolibrary.org/obo/CHEBI_52279|http://purl.obolibrary.org/obo/CHEBI_9532 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T28 | 72-81 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T275 | 0-107 | Sentence | denotes | The novel coronavirus is the first epidemic disease to emerge since the formation of CEPI in Davos in 2017. |
| T276 | 108-230 | Sentence | denotes | CEPI was created with the express intent to enable speedy research and development of vaccines against emerging pathogens. |
| T277 | 231-422 | Sentence | denotes | In May 2017, WHO released the Target Product Profile (TPP) for MERS-CoV vaccines, following the prioritization of MERS-CoV as one of eight priority pathogens for prevention of epidemics [73]. |
| T278 | 423-632 | Sentence | denotes | CEPI and partners aim to use existing platforms—that is, the existing “backbone” that can be adapted for use against new pathogens—that are currently in preclinical development for MERS-CoV vaccine candidates. |
| T279 | 633-937 | Sentence | denotes | Following the WHO declaration on 30 January that the current 2019-nCoV outbreak is a public health emergency of international concern (PHEIC), global health organizations and researchers will be further mobilized—bolstered by new mechanisms for action and greater resources—to stop the spread of disease. |